Nerve growth factor suppresses prostate tumor growth

Journal of Pharmacological Sciences

Volumn 112, Issue 4, 2010, Pages 463-466

  Goda, Mitsuhiro ^a   Atagi, Saori ^a   Amitani, Keisuke ^a   Hobara, Narumi ^b   Kitamura, Yoshihisa ^c   Kawasaki, Hiromu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Angiogenesis; Nerve growth factor; Prostate tumor growth

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROSTATE CARCINOMA; SMOOTH MUSCLE FIBER; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 77951241385     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09354SC     Document Type: Article

References (15)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-31.
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-257.
3. Hori K, Zhang QH, Li HC, Saito S. Variation of growth rate of a rat tumour during a light-dark cycle: correlation with circadian fluctuations in tumour blood flow. Br J Cancer. 1995;71:1163-1168.
4. Kawasaki H, Takasaki K, Saito A, Goto K. Calcitonin gene-related peptide acts as a vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature. 1988;335:164-167.
5. Fujiwara T, Uehara Y. The cytoarchitecture of the wall and the innervation pattern of the microvessels in the rat mammary gland: a scanning electron microscopic observation. Am J Anat. 1984;170:39-54.
6. Fleming BP, Gibbins IL, Morris JL, Gannon BJ. Noradrenergic and peptidergic innervation of the extrinsic vessels and microcirculation of the rat cremaster muscle. Microvasc Res. 1989;38: 255-268.
7. Chamary VL, Robson T, Loizidou M, Boulos PB, Burnstock G. Progressive loss of perivascular nerves adjacent to colorectal cancer. Eur J Surg Oncol. 2000;26:588-593.
8. Korsching S, Thoenen H. Nerve growth factor in sympathetic ganglia and corresponding target organs of the rat: correlation with density of sympathetic innervation. Proc Natl Acad Sci U S A. 1983;80:3513-3516.
9. Hobara N, Goda M, Takayama F, Kitamura Y, Kawasaki H. Innervation and functional changes in mesenteric perivascular calcitonin gene-related peptide (CGRP)- and neuropeptide Y (NPY)-containing nerves following topical phenol treatment. Neuroscience. 2006;141:1087-1099.
10. Sigala S, Faraoni I, Botticini D, Paez-Pereda M, Missale C, Bonmassar E, et al. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines. Clin Cancer Res. 1999;5:1211-1218.
11. Turrini P, Gaetano C, Antonelli A, Capogrossi MC, Aloe L. Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia. Neurosci Lett. 2002;323:109-112.
12. Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A. 2001;98:6162-6167.
13. Kraemer R, Nguyen H, March KL, Hempstead B. NGF activates similar intracellular signaling pathways in vascular smooth muscle cells as PDGF-BB but elicits different biological responses. Arterioscler Thromb Vasc Biol. 1999;19:1041-1050.
14. Mukouyama YS, Shin D, Britsch S, Taniguchi M, Anderson DJ. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell. 2002;109:693-705.
15. Satoh N, Yamada Y, Kinugasa Y, Takakura N. Angiopoietin-1 alters tumor growth by stabilizing blood vessels or by promoting angiogenesis. Cancer Sci. 2008;99:2373-2379.